Weight Loss
Managing GLP-1 Side Effects: What Helps and When to Call
Updated October 31, 2026 · 7 min read
Most GLP-1 side effects are stomach-related, led by nausea, diarrhea, vomiting and constipation. In studies of FDA-approved semaglutide and tirzepatide, they showed up mostly while the dose was being raised and usually eased over time. Small meals, steady fluids and slowly added fiber can help. Call your provider right away about severe stomach pain, gallbladder symptoms or signs of dehydration.
At Padgett Medical Center in Ocala, personalized compounded semaglutide and personalized compounded tirzepatide are both weekly GLP-1 injections. Side-effect rates below come from research and labeling for FDA-approved products, not from Padgett's personalized compounded medications. Report what you feel, and never change your dose yourself.
Which GLP-1 side effects are most common, and when do they start?
Stomach and bowel effects top the list, and they tend to arrive with dose increases. In the labels' weight-loss trials, 73% of people on FDA-approved semaglutide had a digestive side effect (47% on placebo), as did 56% on FDA-approved tirzepatide (30% on placebo). Nausea led on both. The labels warn that rates from separate trials can't be compared directly.
Tiredness, indigestion, belching and heartburn were also more common on both drugs than on placebo. A pooled analysis of three trials of FDA-approved semaglutide found 98% of digestive side effects were mild or moderate, and most were temporary. Your first month on personalized compounded semaglutide covers the early weeks.
What helps with nausea and vomiting?
Eat small amounts often, and don't let yourself get very hungry. A 2025 advisory from four medical and nutrition groups says nausea often strikes in the morning or after long stretches without food, and that skipping meals because of it can start a loop that makes it worse.
It suggests a small breakfast, then small meals every three to four hours, with enough to drink. Large meals make vomiting more likely, and avoiding fatty and high-fiber foods in the first few days of treatment can ease symptoms. Ginger tea, peppermint tea or an acupressure wristband helps some people.
In the pooled analysis of FDA-approved semaglutide, half of nausea episodes ended within 8 days, and half of vomiting episodes within 2. If eating changes aren't enough, ask your provider about anti-nausea medicine; some kinds can worsen constipation, the advisory notes.
What helps with constipation or diarrhea?
For constipation, start early with fluids and fiber-rich foods such as prunes and other dried fruit, adding fiber slowly, as the advisory suggests. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says regular physical activity may help, and that your health care professional may recommend a laxative for a short time.
Constipation lasts longer: in the pooled analysis of FDA-approved semaglutide, half of episodes lasted 47 days or more, versus 35 days on placebo. Call your provider if it turns severe or won't let up. Both labels list severe constipation, including stool that gets stuck, and intestinal blockage among problems reported since approval.
For diarrhea, drink water plus liquids with electrolytes, such as broth or sports drinks, as NIDDK advises, and keep meals small and low in fat, as the advisory suggests. If you're an older adult or have diabetes, kidney disease or another health condition, check with your provider before using an oral rehydration solution, a drink with sugar and electrolytes. Half of diarrhea episodes ended within 3 days in the pooled analysis of FDA-approved semaglutide.
Long-lasting constipation can also cause diarrhea, the advisory notes, so mention it if the two alternate, and ask before taking an anti-diarrhea medicine.
How can you ease heartburn and reflux?
Give your stomach time before you lie down, raise your head at night and learn your triggers. NIDDK says finishing meals at least 3 hours before you lie down may ease reflux that bothers you at night.
NIDDK's list of common triggers includes alcohol, caffeine, chocolate, high-fat and spicy foods, citrus fruits, tomatoes and mint. The advisory adds that alcohol can worsen nausea and reflux on a GLP-1.
NIDDK's reflux treatment guidance suggests a foam wedge or extra pillows under your head and upper back to raise your head 6 to 8 inches. Antacids can ease mild heartburn, but NIDDK says not to use them every day, or for severe symptoms, without talking with your doctor.
Why do you feel tired on a GLP-1, and what helps?
Fatigue is a listed side effect: in weight-loss trials it affected 11% of people on FDA-approved semaglutide versus 5% on placebo, and up to 7% on FDA-approved tirzepatide versus 3%. The advisory notes that these medicines cut calorie intake by 16% to 39%, which can leave you short on vitamins and minerals, and it lists fatigue beyond what you'd expect among the signs of a deficiency.
Dehydration can also make you tired, NIDDK says. Weakness, sweating or shakiness can mean low blood sugar; the labels say insulin and sulfonylureas, a type of diabetes pill, raise the risk, and the label for FDA-approved semaglutide adds past weight-loss surgery. Eat small, regular meals, start each one with its protein as the advisory suggests, and sip fluids all day; protein and muscle on a GLP-1 has more. Report tiredness that won't go away.
What can you do about redness or itching where you inject?
Rotate sites and follow the instructions for your exact medication. Injection-site reactions such as redness, itching, bruising or pain were reported by 6% to 8% of people on FDA-approved tirzepatide, versus 2% on placebo. With FDA-approved semaglutide, 1.4% had one, versus 1% on placebo.
Both Medication Guides, the FDA-approved patient leaflets, say to pick a new injection site each time; the one for FDA-approved tirzepatide allows a new spot in the same area. Report a reaction that bothers you or doesn't fade.
Call 911 for signs of a serious allergic reaction, which the guides list as swelling of your face, lips, tongue or throat, trouble breathing or swallowing, a severe rash or itching, fainting or dizziness, or a very fast heartbeat.
Which symptoms mean you should call your provider right away?
Call right away about severe stomach problems or signs of pancreatitis, gallbladder disease or dehydration, which the FDA-approved labels warn about. Pancreatitis, an inflamed pancreas, can cause severe pain in your stomach area that won't go away, with or without nausea or vomiting, sometimes reaching your back.
Gallbladder trouble can cause upper stomach pain, fever, yellowing skin or eyes, or clay-colored stools, and some cases need surgery. The label for FDA-approved semaglutide says substantial or rapid weight loss can raise the risk of gallstones, but gallbladder problems were more common on the drug than on placebo even after accounting for weight loss.
Nausea, vomiting or diarrhea that won't go away can dehydrate you; the labels describe kidney injury, sometimes needing dialysis, mostly in people dehydrated this way. NIDDK's signs of dehydration include extreme thirst or a dry mouth, urinating less than usual, dark urine and feeling dizzy or lightheaded. It also says to talk with a doctor right away about frequent vomiting, diarrhea lasting more than 2 days, six or more loose stools a day, or black or bloody stools.
Both guides also ask you to report a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath, possible symptoms of thyroid cancer. The guide for FDA-approved semaglutide adds a racing or pounding heartbeat at rest that lasts several minutes. If symptoms are severe and you can't reach the clinic, call 911 or go to an emergency room.
Should you change your dose to stop side effects?
No. Dose changes belong to your provider, who knows your history and how you handled each increase. When a dose isn't tolerated, the label for FDA-approved semaglutide lets the prescriber wait longer before the next increase, and the one for FDA-approved tirzepatide allows a lower maintenance dose.
Skipping injections for a break is a schedule change too; ask your provider first. Your provider may prescribe your weekly amount as two smaller injections, for example Monday and Thursday, when side effects call for it. Never change your schedule yourself.
Our article on splitting a tirzepatide dose twice a week explains why the FDA-approved product is dosed weekly. If side effects keep getting in the way, ask whether another option fits, such as phentermine weight loss in Ocala, an appetite-suppressant pill labeled for short-term use.
How does Padgett help with side effects in Ocala?
Your visits are with Sarah Weir, APRN, an advanced practice registered nurse, at 200 SW 8th St., Suite A, just south of downtown Ocala, or by telehealth anywhere in Florida while you're physically in Florida. Care is medically supervised, and your provider personalizes your dose and adjusts it with you over time.
Report side effects at follow-ups, in person or by telehealth, and between visits call (352) 369-0104, Monday to Friday, 9:00 AM to 5:00 PM. Personalized compounded semaglutide starts at $149 a month and personalized compounded tirzepatide at $229 a month, at the starting dose. The monthly price is your medication. Your provider visit is $100 and is free when you start medication at that visit; the only other charge is a $50 no-show fee.
Ready to start? Book a weight-loss visit in person in Ocala or by telehealth. Nothing is charged when you book.
Personalized compounded semaglutide and personalized compounded tirzepatide are compounded drugs that have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved products containing semaglutide and tirzepatide are available. Individual results vary.
This article is educational and is not medical advice. Talk with a licensed provider about your own health, medications and treatment options.
Pending medical review. This article is educational and is not medical advice. Never start, stop, split or change the timing of a prescription based on something you read online. Your provider decides your dose and your schedule.
Frequently asked questions
Can a GLP-1 cause hair loss?
It can, though less often than stomach side effects. In weight-loss trials of FDA-approved semaglutide and tirzepatide, about 3% to 6% of people had hair loss versus 1% on placebo, more often women. Both labels link it to weight reduction. A 2025 nutrition advisory lists excessive hair loss as a possible sign of a nutrient deficiency, so tell your provider.
Can I take over-the-counter medicine for nausea, heartburn or constipation?
Ask your provider or pharmacist first. The Medication Guides for FDA-approved semaglutide and tirzepatide ask you to share every prescription and over-the-counter medicine, vitamin and herbal supplement you take, and these drugs slow stomach emptying, which can change how some pills are absorbed. NIDDK also warns against daily antacid use without your doctor's input.
Can a GLP-1 make your skin tingle or burn?
It can. The label for FDA-approved semaglutide lists changes in skin sensation, such as tingling, burning, skin pain or sensitive skin, among its common side effects and says they grew more common at higher doses. In weight-loss trials of FDA-approved tirzepatide, under 1% of people reported them. Tell your provider instead of adjusting your dose.
Do side effects mean my dose is too high?
Not necessarily. In a pooled analysis of trials of FDA-approved semaglutide, most stomach side effects were mild or moderate and didn't require a lower dose or stopping treatment, though a small share of people had them throughout. Only your provider can judge your dose, so describe how you feel instead of cutting back on your own.
What should I have ready when I call about a side effect?
Know what the symptom is, when it started and how it lines up with your injection day. Have your current dose handy, plus how much you're eating, drinking and urinating, and any new medicines or supplements. With that, your provider can decide whether to change your plan, so you don't have to guess.
Sources
- Prescribing information and Medication Guide for FDA-approved semaglutide injection and tablets for weight reduction (Novo Nordisk, revised 6/2026), DailyMed, U.S. National Library of Medicine
- Prescribing information and Medication Guide for FDA-approved tirzepatide injection for weight reduction and obstructive sleep apnea (Eli Lilly and Company, revised 8/2026), DailyMed, U.S. National Library of Medicine
- Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss, Diabetes, Obesity and Metabolism, 2022, PubMed Central
- Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society, American Journal of Clinical Nutrition, 2025, PubMed Central
- Eating, Diet, & Nutrition for GER & GERD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Symptoms & Causes of Diarrhea, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
